Early manifestations of restless legs syndrome in childhood and adolescence DL Picchietti, HE Stevens Sleep medicine 9 (7), 770-781, 2008 | 237 | 2008 |
Why the diagnosis of attention deficit hyperactivity disorder matters AM Hamed, AJ Kauer, HE Stevens Frontiers in psychiatry 6, 168, 2015 | 212 | 2015 |
Maternal inflammation and neurodevelopmental programming: a review of preclinical outcomes and implications for translational psychiatry SB Gumusoglu, HE Stevens Biological psychiatry 85 (2), 107-121, 2019 | 175 | 2019 |
Neurodevelopmental outcomes of prenatal preeclampsia exposure SB Gumusoglu, ASS Chilukuri, DA Santillan, MK Santillan, HE Stevens Trends in neurosciences 43 (4), 253-268, 2020 | 124 | 2020 |
Risk and resilience: early manipulation of macaque social experience and persistent behavioral and neurophysiological outcomes HE Stevens, JF Leckman, JD Coplan, SJ Suomi Journal of the American Academy of Child & Adolescent Psychiatry 48 (2), 114-127, 2009 | 123 | 2009 |
Prenatal stress and genetic risk: How prenatal stress interacts with genetics to alter risk for psychiatric illness PW Abbott, SB Gumusoglu, J Bittle, DQ Beversdorf, HE Stevens Psychoneuroendocrinology 90, 9-21, 2018 | 121 | 2018 |
The role of IL-6 in neurodevelopment after prenatal stress SB Gumusoglu, RS Fine, SJ Murray, JL Bittle, HE Stevens Brain, behavior, and immunity 65, 274-283, 2017 | 120 | 2017 |
Prenatal stress and inhibitory neuron systems: implications for neuropsychiatric disorders R Fine, J Zhang, HE Stevens Molecular psychiatry 19 (6), 641-651, 2014 | 119 | 2014 |
Regulation of cerebral cortical size and neuron number by fibroblast growth factors: implications for autism FM Vaccarino, EL Grigorenko, KM Smith, HE Stevens Journal of autism and developmental disorders 39, 511-520, 2009 | 96 | 2009 |
Prenatal stress delays inhibitory neuron progenitor migration in the developing neocortex HE Stevens, T Su, Y Yanagawa, FM Vaccarino Psychoneuroendocrinology 38 (4), 509-521, 2013 | 94 | 2013 |
Prenatal stress, maternal immune dysregulation, and their association with autism spectrum disorders DQ Beversdorf, HE Stevens, KL Jones Current psychiatry reports 20, 1-12, 2018 | 90 | 2018 |
Fgfr2 is required for the development of the medial prefrontal cortex and its connections with limbic circuits HE Stevens, KM Smith, ME Maragnoli, D Fagel, E Borok, M Shanabrough, ... Journal of Neuroscience 30 (16), 5590-5602, 2010 | 86 | 2010 |
Delays in GABAergic interneuron development and behavioral inhibition after prenatal stress SJ Lussier, HE Stevens Developmental neurobiology 76 (10), 1078-1091, 2016 | 77 | 2016 |
Maternal nicotinamide riboside enhances postpartum weight loss, juvenile offspring development, and neurogenesis of adult offspring PH Ear, A Chadda, SB Gumusoglu, MS Schmidt, S Vogeler, J Malicoat, ... Cell reports 26 (4), 969-983. e4, 2019 | 72 | 2019 |
Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders HE Stevens, KM Smith, BG Rash, FM Vaccarino Frontiers in neuroscience 4, 59, 2010 | 69 | 2010 |
Fibroblast growth factor 2 modulates hypothalamic pituitary axis activity and anxiety behavior through glucocorticoid receptors N Salmaso, HE Stevens, J McNeill, M ElSayed, Q Ren, ME Maragnoli, ... Biological psychiatry 80 (6), 479-489, 2016 | 68 | 2016 |
Hormonal correlates of clozapine-induced weight gain in psychotic children: an exploratory study AL Sporn, AJ Bobb, N Gogtay, H Stevens, DK Greenstein, LIVS Clasen, ... Journal of the American Academy of Child & Adolescent Psychiatry 44 (9), 925-933, 2005 | 64 | 2005 |
Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders FM Vaccarino, HE Stevens, A Kocabas, D Palejev, A Szekely, ... Neuropharmacology 60 (7-8), 1355-1363, 2011 | 56 | 2011 |
Learning and memory depend on fibroblast growth factor receptor 2 functioning in hippocampus HE Stevens, GY Jiang, ML Schwartz, FM Vaccarino Biological psychiatry 71 (12), 1090-1098, 2012 | 52 | 2012 |
Prenatal stress and maternal immune dysregulation in autism spectrum disorders: potential points for intervention DQ Beversdorf, HE Stevens, KG Margolis, J Van de Water Current pharmaceutical design 25 (41), 4331-4343, 2019 | 45 | 2019 |